We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01033760
Recruitment Status : Completed
First Posted : December 16, 2009
Last Update Posted : February 5, 2014
Gilead Sciences
Merck Sharp & Dohme Corp.
Janssen-Cilag Ltd.
Information provided by (Responsible Party):
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)